you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01020 | SECTOR: Pharmaceuticals

BSE Live

Jan 15, 16:00
2111.40 -36.90 (-1.72%)
Volume
AVERAGE VOLUME
5-Day
8,011
10-Day
8,336
30-Day
14,827
5,343
  • Prev. Close

    2148.30

  • Open Price

    2174.85

  • Bid Price (Qty.)

    2111.40 (47)

  • Offer Price (Qty.)

    2129.00 (25)

NSE Live

Jan 15, 16:01
2108.35 -40.60 (-1.89%)
Volume
AVERAGE VOLUME
5-Day
274,800
10-Day
241,217
30-Day
289,283
175,651
  • Prev. Close

    2148.95

  • Open Price

    2148.95

  • Bid Price (Qty.)

    2108.35 (4)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Nine Months Results of Ipca Laboratories (in Rs. Cr.) Dec '19 Dec '18 Dec '17 Dec '16 Dec '15  
Net Sales/Income from operations 3,362.64 2,799.34 2,436.46 2,405.27 2,159.55  
Other Operating Income -- -- -- 48.68 29.23  
Total Income From Operations 3,362.64 2,799.34 2,436.46 2,453.95 2,188.78  
EXPENDITURE  
Consumption of Raw Materials 1,060.04 831.88 699.66 715.64 706.40  
Purchase of Traded Goods 153.80 123.83 125.22 120.86 102.20  
Increase/Decrease in Stocks -60.08 -64.93 31.61 39.05 20.29  
Power & Fuel -- -- -- -- --  
Employees Cost 642.91 575.42 544.22 516.19 454.12  
Depreciation 133.31 130.27 131.21 128.22 116.85  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 843.93 814.64 704.00 695.28 652.13  
P/L Before Other Inc. , Int., Excpt. Items & Tax 588.73 388.23 200.54 238.71 136.79  
Other Income 51.39 40.01 28.15 16.99 16.09  
P/L Before Int., Excpt. Items & Tax 640.12 428.24 228.69 255.70 152.88  
Interest 12.32 12.24 17.57 23.20 57.10  
P/L Before Exceptional Items & Tax 627.80 416.00 211.12 232.50 95.78  
Exceptional Items -- -- -- -- --  
P/L Before Tax 627.80 416.00 211.12 232.50 95.78  
Tax 103.10 70.56 29.32 88.60 36.20  
P/L After Tax from Ordinary Activities 524.70 345.44 181.80 143.90 59.58  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 524.70 345.44 181.80 143.90 59.58  
Equity Share Capital 25.27 25.27 25.24 25.24 25.24  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 41.53 27.34 14.41 11.40 4.72  
Diluted EPS 41.51 27.34 14.41 11.40 4.72  
EPS After Extra Ordinary  
Basic EPS. 41.53 27.34 14.41 11.40 4.72  
Diluted EPS. 41.51 27.34 14.41 11.40 4.72  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited